Bifogade filer
Kurs
-1,86%
Likviditet
0,31 MSEK
Kalender
Est. tid* | ||
2025-11-20 | N/A | Årsstämma |
2025-11-14 | 09:00 | Kvartalsrapport 2026-Q1 |
2025-08-28 | 08:30 | Bokslutskommuniké 2025 |
2025-05-22 | 09:00 | Kvartalsrapport 2025-Q3 |
2025-03-11 | - | Extra Bolagsstämma 2025 |
2025-02-13 | - | Kvartalsrapport 2025-Q2 |
2024-11-22 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
2024-11-21 | - | Årsstämma |
2024-11-15 | - | Kvartalsrapport 2025-Q1 |
2024-08-28 | - | Bokslutskommuniké 2024 |
2024-05-24 | - | Kvartalsrapport 2024-Q3 |
2024-02-22 | - | Kvartalsrapport 2024-Q2 |
2023-12-14 | - | Extra Bolagsstämma 2024 |
2023-11-24 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
2023-11-23 | - | Årsstämma |
2023-11-17 | - | Kvartalsrapport 2024-Q1 |
2023-08-28 | - | Bokslutskommuniké 2023 |
2023-05-26 | - | Kvartalsrapport 2023-Q3 |
2023-05-17 | - | Extra Bolagsstämma 2023 |
2023-02-23 | - | Kvartalsrapport 2023-Q2 |
2022-11-25 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
2022-11-24 | - | Årsstämma |
2022-11-11 | - | Kvartalsrapport 2023-Q1 |
2022-08-26 | - | Bokslutskommuniké 2022 |
2022-05-20 | - | Kvartalsrapport 2022-Q3 |
2022-02-25 | - | Kvartalsrapport 2022-Q2 |
2021-11-26 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
2021-11-25 | - | Årsstämma |
2021-11-11 | - | Kvartalsrapport 2022-Q1 |
2021-08-27 | - | Bokslutskommuniké 2021 |
2021-06-17 | - | Extra Bolagsstämma 2022 |
2021-05-21 | - | Kvartalsrapport 2021-Q3 |
2021-03-02 | - | Extra Bolagsstämma 2021 |
2021-02-26 | - | Kvartalsrapport 2021-Q2 |
2020-11-27 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
2020-11-26 | - | Årsstämma |
2020-11-12 | - | Kvartalsrapport 2021-Q1 |
2020-08-28 | - | Bokslutskommuniké 2020 |
2020-05-22 | - | Kvartalsrapport 2020-Q3 |
2020-02-28 | - | Kvartalsrapport 2020-Q2 |
2019-11-22 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
2019-11-21 | - | Årsstämma |
2019-11-08 | - | Kvartalsrapport 2020-Q1 |
2019-08-30 | - | Bokslutskommuniké 2019 |
2019-05-17 | - | Kvartalsrapport 2019-Q3 |
2019-02-15 | - | Kvartalsrapport 2019-Q2 |
2018-11-16 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
2018-11-15 | - | Årsstämma |
2018-11-09 | - | Kvartalsrapport 2019-Q1 |
2018-08-30 | - | Bokslutskommuniké 2018 |
2018-05-18 | - | Kvartalsrapport 2018-Q3 |
2018-02-16 | - | Kvartalsrapport 2018-Q2 |
2017-11-10 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
2017-11-09 | - | Årsstämma |
2017-11-02 | - | Kvartalsrapport 2018-Q1 |
2017-08-18 | - | Bokslutskommuniké 2017 |
2017-05-12 | - | Kvartalsrapport 2017-Q3 |
2017-02-10 | - | Kvartalsrapport 2017-Q2 |
2017-01-19 | - | Extra Bolagsstämma 2018 |
2016-11-18 | - | Kvartalsrapport 2017-Q1 |
2016-11-11 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
2016-11-10 | - | Årsstämma |
2016-08-19 | - | Bokslutskommuniké 2016 |
2016-05-13 | - | Kvartalsrapport 2016-Q3 |
2016-02-12 | - | Kvartalsrapport 2016-Q2 |
2015-11-13 | - | Kvartalsrapport 2016-Q1 |
Beskrivning
Land | Sverige |
---|---|
Lista | Spotlight |
Sektor | Hälsovård |
Industri | Bioteknik |
Professor Gabriela Godaly is working with Hamlet BioPharma to develop a new therapeutic concept to combat tuberculosis through the use of a bactericidal peptide. The drug candidates has demonstrated potent effects in animal models. Tuberculosis is one of the top ten causes of death world-wide and the growing problem of drug resistance is seriously affecting the treatment options for this patient group.
The Nobel Symposium in Chemistry october 23-27, 2023 is a collaborative initiative led by the Stellenbosch Institute for Advanced Study (STIAS) and Stellenbosch University and is organized in partnership with the Nobel Foundation and the Royal Swedish Academy of Sciences, with generous support from the Knut & Alice Wallenberg Foundation. The symposium aims to explore topics ranging from fundamental drug discovery to clinical applications.
Event Details:- Title: Novel treatment for pulmonary tuberculosis
- Date: Thursday, October 26th
- Time: 11:30 AM to 12:00 PM (SAST)
- Presenter: Gabriela Godaly, Lund University, Sweden
For more information about the coference, please click https://stias.ac.za/wp-content/uploads/2023/10/NS178-Chemistry-2023-programme-Proof-11.pdf
For further information, please contact:
Gabriela Godaly, Professor, MIG Department, Institution of Laboratory Medicine, Lund University, Sweden
Gabriela.godaly@med.lu.se
Catharina Svanborg, Chairman and Founder of Hamlet BioPharma, +46-709 42 65 49
catharina.svanborg@hamletpharma.com